Sahajanand Medical Technologies Limited

This study is testing a special stent called Supraflex Cruz in 1000 people who have blockages in more than one heart artery. The stent is coated with a drug (sirolimus) that slowly releases to help keep the artery open, and the coating dissolves over time. Researchers want to see…

This study is testing a new device called the Hydra Transcatheter Aortic Valve System in 500 people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow. The device is implanted through a catheter, avoiding open-heart surgery. Researchers will tr…

This study is testing a new heart valve called Hydra for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. About 250 participants will get the valve through a tube in an artery, and researchers will check how safe and effective it is for…

This study is testing a new heart valve called Hydra in 50 people with severe aortic stenosis, a condition where the heart's main valve narrows. The goal is to see if the valve is safe and works well for up to one year after a minimally invasive replacement procedure. Researchers…

This registry is tracking 10,000 patients with coronary artery disease who receive the Supraflex sirolimus-eluting stent during routine care. The goal is to see how well the stent works in everyday practice, measuring outcomes like heart-related death, heart attacks, and the need…